Institut de cancérologie Strasbourg Europe

Strasbourg 67200

0 studies enrolling now · 4 studies all time

What they study most

Advanced Malignant Solid Tumor, Breast Adenocarcinoma, Breast Cancer, Breast Cancer Female, Breast Neoplasms, Cancer, Breast, Colorectal Cancer, ER Positive, Estrogen Receptor Positive Tumor, Estrogen-receptor Positive Breast Cancer, HER2 Amplification, HER2 Positive Solid Tumors

Studies at this site

• A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function — Stopped early
• ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer — Running, not enrolling
• Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer — Running, not enrolling
• Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer — Completed